SCHEMBL24722970

SCHEMBL24722970

CN1CCC(n2cc(-c3cn(S(=O)(=O)c4ccccc4)c4nnc(Cl)cc34)cn2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK1 P23458 1/20 0.39
CYP3A4 P08684 2/20 0.37
CYP2D6 P10635 1/20 0.37
PAK1 Q13153 1/20 0.37
TNIK Q9UKE5 1/20 0.37
HTR6 P50406 4/20 0.36
MAP3K7 O43318 4/20 0.36
TAB1 Q15750 4/20 0.36
GSK3B P49841 1/20 0.36
DYRK1A Q13627 1/20 0.36
EGFR P00533 1/20 0.36
BRD4 O60885 1/20 0.35
MELK Q14680 1/20 0.35
ACVR1 Q04771 2/20 0.35
BMPR1A P36894 1/20 0.35
ACVRL1 P37023 1/20 0.35
FGFR1 P11362 1/20 0.35
FGFR2 P21802 1/20 0.35
FGFR3 P22607 1/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24723109 0.91 MET (0.38) JAK1HTR6MAP3K7TAB1GSK3B
SCHEMBL24722965 0.88 CYP1A2 (0.48) JAK1CYP3A4PAK1MAP3K7TAB1
SCHEMBL24723287 0.88 CYP3A4 (0.46) JAK1CYP3A4CYP2D6PAK1TNIK
SCHEMBL24723202 0.85 MET (0.48) HTR6FGFR1FGFR2FGFR3
SCHEMBL24723058 0.80 PIM1 (0.36) JAK1CYP3A4PAK1HTR6MAP3K7
SCHEMBL16697712 0.80 DYRK1A (0.44) CYP3A4CYP2D6HTR6GSK3BDYRK1A
SCHEMBL25925229 0.79 EGFR (0.39) JAK1HTR6MAP3K7TAB1GSK3B
SCHEMBL24723277 0.78 HTR6 (0.37) JAK1HTR6MAP3K7TAB1GSK3B
SCHEMBL24723737 0.78 HTR6 (0.35) JAK1HTR6MAP3K7TAB1EGFR
SCHEMBL25924810 0.75 MET (0.40) JAK1HTR6MAP3K7TAB1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022166920-A1 PYRROLOPYRIDAZINE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF 杭州中美华东制药有限公司 2022-08-11 WO disclosed